FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316202445> ?p ?o ?g. }

• W2316202445 abstract "Purpose: The purpose of our study is to (a) establish a reproducible mouse model of orthotopic pleural cancer that recapitulates the pathobiology of human pleural malignancy (including primary malignant pleural mesothelioma, lung and metastatic breast cancers), and (b) validate the use of bioluminescence imaging (BLI) and serum biomarker assessment to noninvasively monitor tumor progression and therapy response in preclinical therapeutic trials. Experimental Design and Results: Human mesothelioma and lung cancer cell lines with variable expression levels of the tumor-associated antigen, mesothelin, were retrovirally transduced to stably express GFP-Firefly Luciferase, to facilitate BLI. Orthotopic xenograft mice were established by direct tumor cell inoculation into the pleural space with > 95% engraftment in both athymic nude and SCID-beige mice. The pathobiologic resemblance of the xenograft tumors to human disease was confirmed by demonstrating: (a) visceral and parietal pleural tumor growth 58 pattern, mediastinal lymph node involvement, and diaphragmatic invasion by magnetic resonance imaging (MRI) and histology, (b) strong, sustained expression of tumor markers at advanced stage of disease by WT‐1, Calretinin, Mesothelin, and TTF‐1 immunohistochemistry, and (c) extensive tumor lymphangiogenesis by CD‐34 and LYVE‐1 immunofluorescence. Tumor burden correlated with BLI signal (total flux photons/s) and soluble mesothelin-related peptide, SMRP (Mesomark® ELISA assay) both in vitro and in vivo (Pearson9s correlation r =0.998, p r =0.89, p=0.04, respectively). We determined the accuracy of BLI and SMRP (range 0.4–23nM) in monitoring tumor progression by serial assessment of xenograft mice (n=36, with initial tumor burden of 1×10 3 –1×10 6 cells). In the orthotopic pleural xenografts, BLI signal correlated with SMRP ( r =0.56, p=0.0001); no such correlation was observed in subcutaneous flank or intraperitoneal xenografts. To further demonstrate the reliability of BLI and SMRP to noninvasively monitor therapeutic response, groups of pleural mesothelioma xenografts (n=28) were treated with either: (a) Cisplatin (4mg/kg IP weekly), (b) thoracic radiation (20Gy total in 5 fractions), (c) combination chemoradiation, or (d) no treatment. BLI, SMRP, and survival were followed serially. Therapy response was demonstrated by decreased BLI intensity in mice treated with chemoradiation compared to controls (3.7×10 7 vs 2.0×10 8 photons/s, respectively, p=0.04) as well as decreased SMRP (p=0.03) which correlated with improved survival by Kaplan-Meier analysis (64 vs 34.5 days, p=0.0001). Conclusions: Pleural involvement by solid tumors remains a significant problem in clinical oncology affecting nearly 250,000 patients annually in the U.S. with no validated preclinical model for therapeutic investigations. We have validated a clinically relevant, reproducible orthotopic model of pleural malignancy that recapitulates human disease and allows for noninvasive quantitative monitoring of pleural tumor burden, progression and therapeutic response. Our xenograft model provides a novel platform to investigate targeted therapies for pleural malignancies. Citation Information: Cancer Res 2009;69(23 Suppl):B27." @default.
• W2316202445 created "2016-06-24" @default.
• W2316202445 creator A5015976844 @default.
• W2316202445 creator A5034626553 @default.
• W2316202445 creator A5044306012 @default.
• W2316202445 creator A5055597008 @default.
• W2316202445 creator A5059625599 @default.
• W2316202445 date "2009-12-01" @default.
• W2316202445 modified "2023-09-25" @default.
• W2316202445 title "Abstract B27: A preclinical mouse model of orthotopic pleural cancer that facilitates noninvasive quantitative monitoring of tumor progression and therapy response" @default.
• W2316202445 doi "https://doi.org/10.1158/0008-5472.fbcr09-b27" @default.
• W2316202445 hasPublicationYear "2009" @default.
• W2316202445 type Work @default.
• W2316202445 sameAs 2316202445 @default.
• W2316202445 citedByCount "0" @default.
• W2316202445 crossrefType "proceedings-article" @default.
• W2316202445 hasAuthorship W2316202445A5015976844 @default.
• W2316202445 hasAuthorship W2316202445A5034626553 @default.
• W2316202445 hasAuthorship W2316202445A5044306012 @default.
• W2316202445 hasAuthorship W2316202445A5055597008 @default.
• W2316202445 hasAuthorship W2316202445A5059625599 @default.
• W2316202445 hasConcept C111335760 @default.
• W2316202445 hasConcept C121608353 @default.
• W2316202445 hasConcept C126322002 @default.
• W2316202445 hasConcept C142724271 @default.
• W2316202445 hasConcept C161997846 @default.
• W2316202445 hasConcept C2776107976 @default.
• W2316202445 hasConcept C2777045440 @default.
• W2316202445 hasConcept C2777407522 @default.
• W2316202445 hasConcept C2779013556 @default.
• W2316202445 hasConcept C2780283643 @default.
• W2316202445 hasConcept C2780849966 @default.
• W2316202445 hasConcept C502942594 @default.
• W2316202445 hasConcept C54009773 @default.
• W2316202445 hasConcept C54355233 @default.
• W2316202445 hasConcept C71924100 @default.
• W2316202445 hasConcept C81885089 @default.
• W2316202445 hasConcept C86803240 @default.
• W2316202445 hasConceptScore W2316202445C111335760 @default.
• W2316202445 hasConceptScore W2316202445C121608353 @default.
• W2316202445 hasConceptScore W2316202445C126322002 @default.
• W2316202445 hasConceptScore W2316202445C142724271 @default.
• W2316202445 hasConceptScore W2316202445C161997846 @default.
• W2316202445 hasConceptScore W2316202445C2776107976 @default.
• W2316202445 hasConceptScore W2316202445C2777045440 @default.
• W2316202445 hasConceptScore W2316202445C2777407522 @default.
• W2316202445 hasConceptScore W2316202445C2779013556 @default.
• W2316202445 hasConceptScore W2316202445C2780283643 @default.
• W2316202445 hasConceptScore W2316202445C2780849966 @default.
• W2316202445 hasConceptScore W2316202445C502942594 @default.
• W2316202445 hasConceptScore W2316202445C54009773 @default.
• W2316202445 hasConceptScore W2316202445C54355233 @default.
• W2316202445 hasConceptScore W2316202445C71924100 @default.
• W2316202445 hasConceptScore W2316202445C81885089 @default.
• W2316202445 hasConceptScore W2316202445C86803240 @default.
• W2316202445 hasLocation W23162024451 @default.
• W2316202445 hasOpenAccess W2316202445 @default.
• W2316202445 hasPrimaryLocation W23162024451 @default.
• W2316202445 hasRelatedWork W1973665900 @default.
• W2316202445 hasRelatedWork W1986484515 @default.
• W2316202445 hasRelatedWork W2003700763 @default.
• W2316202445 hasRelatedWork W2017220227 @default.
• W2316202445 hasRelatedWork W2020380655 @default.
• W2316202445 hasRelatedWork W2055394962 @default.
• W2316202445 hasRelatedWork W2059703103 @default.
• W2316202445 hasRelatedWork W2061645158 @default.
• W2316202445 hasRelatedWork W2065270459 @default.
• W2316202445 hasRelatedWork W2083797848 @default.
• W2316202445 hasRelatedWork W2087568374 @default.
• W2316202445 hasRelatedWork W2116281754 @default.
• W2316202445 hasRelatedWork W2123504951 @default.
• W2316202445 hasRelatedWork W2170210944 @default.
• W2316202445 hasRelatedWork W2182653624 @default.
• W2316202445 hasRelatedWork W2345905360 @default.
• W2316202445 hasRelatedWork W2516966370 @default.
• W2316202445 hasRelatedWork W2546666576 @default.
• W2316202445 hasRelatedWork W2944351569 @default.
• W2316202445 hasRelatedWork W3178003730 @default.
• W2316202445 isParatext "false" @default.
• W2316202445 isRetracted "false" @default.
• W2316202445 magId "2316202445" @default.
• W2316202445 workType "article" @default.